Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma
Authors
Keywords
-
Journal
OncoImmunology
Volume 8, Issue 7, Pages 1601478
Publisher
Informa UK Limited
Online
2019-04-18
DOI
10.1080/2162402x.2019.1601478
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
- (2018) Elisa Peranzoni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CSF1R + Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype
- (2018) Juliana B. Candido et al. Cell Reports
- Tumor-associated macrophages: from basic research to clinical application
- (2017) Li Yang et al. Journal of Hematology & Oncology
- The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies
- (2017) Changbin Zhu et al. NEURO-ONCOLOGY
- Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma
- (2017) L. Lisi et al. NEUROSCIENCE LETTERS
- Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth
- (2017) Yu Shi et al. Nature Communications
- Crosstalk between M2 macrophages and glioma stem cells
- (2017) Leora M. Nusblat et al. CELLULAR ONCOLOGY
- CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer
- (2017) Zhenguo Cheng et al. Oncotarget
- Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma
- (2017) Aibin Zhang et al. Cancer Medicine
- Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
- (2017) Michael A. Cannarile et al. Journal for ImmunoTherapy of Cancer
- CD163+CD204+ tumor-associated macrophages contribute to T cell regulation via interleukin-10 and PD-L1 production in oral squamous cell carcinoma
- (2017) Keigo Kubota et al. Scientific Reports
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- CD163 + M2-type tumor-associated macrophage support the suppression of tumor-infiltrating T cells in osteosarcoma
- (2016) Qinglin Han et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- New insights into the multidimensional concept of macrophage ontogeny, activation and function
- (2016) Florent Ginhoux et al. NATURE IMMUNOLOGY
- The New Role of CD163 in the Differentiation of Bone Marrow Stromal Cells into Vascular Endothelial-Like Cells
- (2016) Wei Lu et al. Stem Cells International
- Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade
- (2016) Nina Eissler et al. OncoImmunology
- CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion
- (2015) Fei Wang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Alternatively activated microglia and macrophages in the central nervous system
- (2015) Rafael Franco et al. PROGRESS IN NEUROBIOLOGY
- CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients
- (2015) Li Yang et al. Oncotarget
- Engineering strategies to mimic the glioblastoma microenvironment
- (2014) Andrew Rape et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
- (2014) Carola H. Ries et al. CANCER CELL
- CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
- (2014) Y. Zhu et al. CANCER RESEARCH
- High density of CD68+/CD163+ tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma
- (2014) Francesco Marchesi et al. HEMATOLOGICAL ONCOLOGY
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
- (2014) Peter J. Murray et al. IMMUNITY
- Macrophage phenotypes in atherosclerosis
- (2014) Sophie Colin et al. IMMUNOLOGICAL REVIEWS
- CD163 Expression Was Associated with Angiogenesis and Shortened Survival in Patients with Uniformly Treated Classical Hodgkin Lymphoma
- (2014) Young Wha Koh et al. PLoS One
- Glioma Grade Is Associated with the Accumulation and Activity of Cells Bearing M2 Monocyte Markers
- (2013) M. Prosniak et al. CLINICAL CANCER RESEARCH
- Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse
- (2013) Silke Reinartz et al. INTERNATIONAL JOURNAL OF CANCER
- Therapeutically reeducating macrophages to treat GBM
- (2013) Christopher Garris et al. NATURE MEDICINE
- Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma
- (2013) C. Lu-Emerson et al. NEURO-ONCOLOGY
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Targeting the Hemoglobin Scavenger receptor CD163 in Macrophages Highly Increases the Anti-inflammatory Potency of Dexamethasone
- (2012) Jonas H Graversen et al. MOLECULAR THERAPY
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy
- (2010) Hanne Van Gorp et al. MOLECULAR IMMUNOLOGY
- The CD163-expressing macrophages recognize and internalize TWEAK
- (2009) Juan A. Moreno et al. ATHEROSCLEROSIS
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria
- (2008) B. O. Fabriek et al. BLOOD
- Immunotherapy of malignant brain tumors
- (2008) Duane A. Mitchell et al. IMMUNOLOGICAL REVIEWS
- Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas
- (2008) Y Komohara et al. JOURNAL OF PATHOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search